Singapore markets closed

Abbott Laboratories (ABT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
111.79-0.46 (-0.41%)
At close: 04:02PM EST
111.97 +0.18 (+0.16%)
After hours: 07:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 194.97B
Enterprise value 201.47B
Trailing P/E 28.60
Forward P/E 25.38
PEG Ratio (5 yr expected) 31.34
Price/sales (ttm)4.52
Price/book (mrq)5.47
Enterprise value/revenue 4.62
Enterprise value/EBITDA 18.84

Trading information

Stock price history

Beta (5Y monthly) 0.67
52-week change 3-12.70%
S&P500 52-week change 3-7.75%
52-week high 3130.79
52-week low 393.25
50-day moving average 3109.48
200-day moving average 3107.61

Share statistics

Avg vol (3-month) 34.85M
Avg vol (10-day) 34.93M
Shares outstanding 51.74B
Implied shares outstanding 6N/A
Float 81.73B
% held by insiders 10.73%
% held by institutions 175.93%
Shares short (12 Jan 2023) 414.6M
Short ratio (12 Jan 2023) 43.21
Short % of float (12 Jan 2023) 40.86%
Short % of shares outstanding (12 Jan 2023) 40.84%
Shares short (prior month 14 Dec 2022) 418.09M

Dividends & splits

Forward annual dividend rate 42.04
Forward annual dividend yield 41.82%
Trailing annual dividend rate 31.92
Trailing annual dividend yield 31.71%
5-year average dividend yield 41.53
Payout ratio 448.08%
Dividend date 314 Feb 2023
Ex-dividend date 411 Jan 2023
Last split factor 210000:4798
Last split date 301 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 15.88%
Operating margin (ttm)20.07%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)19.28%

Income statement

Revenue (ttm)43.65B
Revenue per share (ttm)24.75
Quarterly revenue growth (yoy)-12.00%
Gross profit (ttm)24.68B
Net income avi to common (ttm)6.93B
Diluted EPS (ttm)3.91
Quarterly earnings growth (yoy)-48.10%

Balance sheet

Total cash (mrq)9.91B
Total cash per share (mrq)5.68
Total debt (mrq)16.58B
Total debt/equity (mrq)46.20
Current ratio (mrq)N/A
Book value per share (mrq)20.46

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A